It has been a so-so year thus far for PerkinElmer (PKI), and that has been true for many other life sciences companies as well. Thermo Fisher (TMO) and Danaher (DHR) have been stronger (with just under double-digit returns year to date), but Waters (WAT) and Mettler Toledo (MTD) have been weaker, and PerkinElmer has at least kept pace with the S&P 500.
While
I like PerkinElmer's biopharma, diagnostics, and food safety businesses
for the long term, the underlying performance for 2018 looks like it is
on pace for "good, not great". With the shares trading a little below
my typical hurdle rate but still offering a high single-digit estimated
annualized return, I'd call this is a "high-interest hold" at this
point.
Read the full article here:
PerkinElmer Lagging A Bit
No comments:
Post a Comment